DOI: 10.12890/2025_005755
Strawberry gingivitis as the initial manifestation of granulomatosis with polyangiitis in a patient with alpha-1 antitrypsin deficiency
Authors
ayema.haque@wmed.edu
Keywords
Granulomatosis with polyangiitis, strawberry gingivitis, ANCA-associated vasculitis, alpha-1 antitrypsin deficiencyAbstract
Background: Granulomatosis with polyangiitis (GPA) is a systemic necrotizing vasculitis, associated with anti-neutrophil cytoplasmic antibody (ANCA) that typically affects small- to medium-sized vessels in the upper and lower respiratory tracts and kidneys. While oral involvement is uncommon, the pathognomonic finding of “strawberry gingivitis” can be an initial manifestation in rare cases. The gingivitis presents as a friable, hyperplastic, erythematous gingival lesion. Recognizing this manifestation is critical, as it may precede systemic involvement and facilitate early diagnosis and intervention.
Case presentation: We report a case of a 56-year-old male with a history of chronic epistaxis, alpha-1 antitrypsin deficiency, and recent new onset joint pain who presented with a two-month history of painful gums refractory to antibiotic treatment. Histopathology of the lesion as well as - a positive proteinase 3 titre – and a cytoplasmic ANCA staining pattern confirmed GPA and C-reactive protein was elevated. With this diagnosis, he was treated with prednisone and methotrexate and later switched to azathioprine due to potential toxicity, leading to symptom resolution and normalization of inflammatory markers. At 1-year follow-up, he remained clinically stable on azathioprine 100 mg daily.
Conclusion: Our case highlights the importance of recognizing strawberry gingivitis as a rare but pathognomonic early manifestation of GPA. It underscores the need for prompt biopsy and serologic testing for accurate diagnosis and suggests that alpha-1 antitrypsin deficiency should raise clinical suspicion for GPA. Early initiation of immunosuppressive therapy is crucial to prevent progression to severe systemic disease.
References
- Apoita-Sanz M, Blanco-Jauset P, Polis-Yanes C, Penin-Mosquera RM, Montserrat-Gomá G, Pozuelo-Arquimbau L, et al. Granulomatosis with poliangeitis (Wegener’s granulomatosis): orofacial manifestations. Systematic review and case report. Oral Health Prev Dent 2020;18:929-943. doi: 10.3290/j.ohpd.a45433
- Stewart C, Cohen D, Bhattacharyya I, Scheitler L, Riley S, Calamia K, et al. Oral manifestations of Wegener’s granulomatosis: a report of three cases and a literature review. J Am Dent Assoc 2007;138:338–348. doi: 10.14219/jada.archive.2007.0166
- Puéchal X. Granulomatosis with polyangiitis (Wegener’s). Joint Bone Spine 2020;87:572–578. doi: 10.1016/j.jbspin.2020.06.005
- Thompson G, Benwell N, Hollingsworth P, McLean-Tooke A. Two cases of granulomatosis polyangiitis presenting with strawberry gingivitis and a review of the literature. Semin Arthritis Rheum 2018;47:520–523. doi: 10.1016/j.semarthrit.2017.06.003
- Koscielecki K, Kalisz A, Okonska A, Kozakiewicz J, Skorulska I, Dlugozima P, et al. Alpha-1 antitrypsin deficiency pathophysiology, symptoms, diagnosis, treatment. Qual Sport 2025;2025:59389. doi: 10.12775/QS.2025.40.59389
- Pervakova MY, Emanuel VL, Titova ON, Lapin SV, Mazurov VI, Belyaeva IB, et al. The diagnostic value of alpha-1-antitrypsin phenotype in patients with granulomatosis with polyangiitis. Int J Rheumatol 2016;2016:7831410. doi: 10.1155/2016/7831410
- Seyama K, Hirai T, Mishima M, Tatsumi K, Nishimura M. A nationwide epidemiological survey of alpha1-antitrypsin deficiency in Japan. Respir Investig 2016;54:201–206. doi: 10.1016/j.resinv.2015.12.002
- Serres F, Blanco I. Role of alpha-1 antitrypsin in human health and disease. J Intern Med 2014;276:311–335. doi: 10.1111/joim.12239
- Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Rheumatol 2021;73:1366–1383. doi: 10.1002/art.41773
- Serres F. Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed. Environ Health Perspect 2003;111:1851–1854. doi: 10.1289/ehp.6511